Metraipolis › archive › dc_0ee33fd6b2b7
ORBE II Study: Clinical Characteristics and Outcomes After Treatment with Benralizumab According to Airflow Obstruction Status and Smoking Habit — Europe PMC PMID:41302936
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41302936
- DOI
- 10.3390/jcm14227900
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T17:39:15.842Z
- SHA-256 of the archived text
5ed8da57fdc40f4e77ea469e59fd053953b995a4213f05df335ace13dbb45e9b- Stable URL of this page
https://metraipolis.com/documento/dc_0ee33fd6b2b7
How to cite
ORBE II Study: Clinical Characteristics and Outcomes After Treatment with Benralizumab According to Airflow Obstruction Status and Smoking Habit — Europe PMC PMID:41302936 — Europe PMC (en), https://europepmc.org/article/MED/41302936 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0ee33fd6b2b7 (Metraipolis archive dc_0ee33fd6b2b7, sha256 5ed8da57fdc40f4e77ea469e59fd053953b995a4213f05df335ace13dbb45e9b)
BibTeX
@misc{dc0ee33fd6b2b7,
title = {ORBE II Study: Clinical Characteristics and Outcomes After Treatment with Benralizumab According to Airflow Obstruction Status and Smoking Habit — Europe PMC PMID:41302936},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41302936},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0ee33fd6b2b7; sha256 5ed8da57fdc40f4e77ea469e59fd053953b995a4213f05df335ace13dbb45e9b},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41302936. Agents can read the archived copy with the MCP tool read_document.